GRACIELLA MARTINEZ: Open Payments
NPI 1285264937 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,207 in 141 payments from 23 companies in 2025. Trend: 2023 $2,367 · 2024 $595 · 2025 $3,207
Food & beverage: $3,207
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $612 |
| Novo Nordisk Inc | 11 | $324 |
| Amgen Inc. | 21 | $306 |
| ABBVIE INC. | 15 | $261 |
| Phathom Pharmaceuticals, Inc. | 9 | $260 |
| GlaxoSmithKline, LLC. | 21 | $223 |
| Axsome Therapeutics, Inc. | 6 | $219 |
| Abbott Laboratories | 5 | $167 |
| Kowa Pharmaceuticals America, Inc. | 13 | $145 |
| Dexcom, Inc. | 1 | $115 |
Products named: BREZTRI, VOQUEZNA, Auvelity, FARXIGA, TRELEGY ELLIPTA, Ozempic, FREESTYLE LIBRE 3, OTEZLA.
Industry payments across TX — which companies pay providers there.
